Filing metadata

Accession number
0001209191-17-041478
Form type
Form 4
Filer
Ultragenyx Pharmaceutical Inc.
CIK
CIK 1515673
Filed
Jun 22, 2017
Reporting period
Jun 22, 2017
Description
Insider transaction

Explore SEC Filings Hub